<!DOCTYPE html>
<html lang="" xml:lang="">
  <head>
    <title>Inference for model-agnostic variable importance</title>
    <meta charset="utf-8" />
    <meta name="author" content="Brian D. Williamson, PhD   Fred Hutchinson Cancer Research Center" />
    <link href="index_files/tile-view-0.2.3.9000/tile-view.css" rel="stylesheet" />
    <script src="index_files/tile-view-0.2.3.9000/tile-view.js"></script>
    <link href="index_files/font-awesome-5.3.1/css/fontawesome-all.min.css" rel="stylesheet" />
    <link rel="stylesheet" href="xaringan-themer.css" type="text/css" />
  </head>
  <body>
    <textarea id="source">
class: center, middle, title-slide

# Inference for model-agnostic variable importance
### Brian D. Williamson, PhD<br> <span style="font-size: 75%;"> Fred Hutchinson Cancer Research Center </span>
### 4 May, 2021<br> <a href = 'https://bdwilliamson.github.io/#talks' style = 'color: white;'>https://bdwilliamson.github.io/#talks</a>

---




&lt;style type="text/css"&gt;
.remark-slide-content {
    font-size: 20px;
    header-h2-font-size: 1.75rem;
}
&lt;/style&gt;

## Research team

This work was done in collaboration with:
&lt;img src="img/people1.PNG" width="65%" style="display: block; margin: auto;" /&gt;
&lt;img src="img/people2.PNG" width="55%" style="display: block; margin: auto;" /&gt;

---

## Motivation: HIV envelope and antibody targets

&lt;img src="img/hiv_env.png" width="90%" style="display: block; margin: auto;" /&gt;

.small[Source: Koff and Berkley (2010)]

---

## Motivation: AMP

AMP overall objective: assess .blue2[VRC01] .blue1[prevention efficacy] (PE) against HIV-1

* &amp;zwj;VRC01: broadly neutralizing antibody (bnAb) isolated from donor

--

Key secondary question:

.green[Which genetic mutations] make HIV-1 .purple[susceptible] to neutralization?

--

&amp;zwj;Challenges:
* How should we measure susceptibility?
--

* How do we determine if a mutation has a real effect?
--

 at .red[many] positions?
--

* Can we use .mutedred[machine learning]?

---

## Variable importance: what and why

**What is variable importance?**
* .blue1[Quantification of "contributions" of a variable] (or a set of variables)

--

  Traditionally: contribution to .blue2[predictions]
--

* Useful to distinguish between contributions of predictions...
--

  * (.blue1[extrinsic importance]) ... .blue1[by a given (possibly black-box) algorithm]
  .small[ [e.g., Breiman, (2001)] ]
--

  * (.blue1[intrinsic importance]) ... .blue1[by best possible (i.e., oracle) algorithm]
  .small[ [e.g., van der Laan (2006)] ]
--

* Our work focuses on .blue1[interpretable, model-agnostic intrinsic importance]

--

Example uses of .blue2[intrinsic] variable importance:
* is it worth extracting text from notes in the EHR for the sake of predicting hospital readmission?

--

* is it worth collecting a given covariate for the sake of predicting neutralization sensitivity?


---

## Case study: ANOVA importance

Data unit `\((X, Y)\)` with:
* outcome `\(Y\)` 
* covariate `\(X := (X_1, X_2, \ldots, X_p)\)`

--

**Goals:** 
* .green[estimate]
* .blue1[and do inference on]

the importance of `\((X_j: j \in s)\)` in predicting `\(Y\)`

--

How do we typically do this in **linear regression**?

---

## Case study: ANOVA importance

How do we typically do this in **linear regression**?

* Fit a linear regression of `\(Y\)` on `\(X\)` `\(\rightarrow \color{magenta}{\hat{\mu}(X)}\)`
--

* Fit a linear regression of `\(Y\)` on `\(X_{-s}\)` `\(\rightarrow \color{magenta}{\hat{\mu}_s(X)}\)`
--

* .green[Compare the fitted values] `\([\hat{\mu}(X_i), \hat{\mu}_s(X_i)]\)`

--

Many ways to compare fitted values, including:
* ANOVA decomposition
* Difference in `\(R^2\)`

--

Can extend this to a .blue1[nonparametric] measure using .blue2[population quantities] 

--

Can do .blue1[inference] on this parameter, even if we used .green[machine learning] 

.small[[details in Williamson et al. (2020a)]]

---

## A unified framework

Our proposed general framework for inference on **model-agnostic** variable importance:
--

1. Choose a .blue2[scientifically relevant] measure of .blue1[predictiveness] `\(V\)`

--

  * Large `\(V\)` = good predictions
  * e.g., classification accuracy, AUC, `\(R^2\)`

--

2. Define variable importance as 

  `\(V(\)` .blue1[best possible] prediction function using .green[all variables] `\() -\)`
  
  `\(V(\)` .blue1[best possible] prediction function .red[excluding the variables of interest] `\()\)`

--

.blue1[Inference] possible even with machine learning! .small[ [Details in Williamson et al. (2020b)] ]

Implemented in `R` package `vimp` (available on `CRAN`!)

---

## Preparing for AMP

&lt;img src="img/vim_ic50.censored_pres_r2_acc_auc_conditional_simple.png" width="60%" style="display: block; margin: auto;" /&gt;

&amp;zwj;Implications:

* All sites in the VRC01 binding footprint, CD4 binding sites appear important

* Results may differ based on chosen measure

.small[ _Data sourced from the CATNAP database (Yoon et al., 2015)_ ]


---

## Extensions and future work

Handling potentially correlated features: 

&lt;img src="img/spvim.png" width="50%" style="display: block; margin: auto;" /&gt;

Assessing neutralization potential of combination bnAb regimens: 

&lt;img src="img/slapnap.png" width="50%" style="display: block; margin: auto;" /&gt;

Variable selection using population importance: my postdoctoral focus

---

## Working towards equity, diversity, and inclusion

My personal goal: work towards EDI in biomedical research and practice

--

**Educational outreach:** [Hutch United Outreach Committee](https://www.fredhutch.org/en/research/education-training/hutch-united.html)

**Mentoring:** [Cientifico Latino](https://www.cientificolatino.com/gsmi), [Pomona College alumni mentor](https://www.sagepost47.com/)

**Research:**
  * working with historically underserved communities
  * working to reduce health disparities
  * increasing access to high-quality preventive care

---

## HU + SCC MESA Partnership

&lt;img src="img/hu-mesa.png" width="100%" style="display: block; margin: auto;" /&gt;

.small[ _Images courtesy of Stephanie Shadbolt_ ]
---

## 2021 FH / SCC virtual internships

&lt;img src="img/people3.png" width="85%" style="display: block; margin: auto;" /&gt;

--

&lt;img src="img/internship_timeline1.PNG" width="70%" style="display: block; margin: auto;" /&gt;

---

## 2021 FH / SCC virtual internships

&lt;img src="img/people3.png" width="85%" style="display: block; margin: auto;" /&gt;

&lt;img src="img/internship_timeline2.PNG" width="70%" style="display: block; margin: auto;" /&gt;

---

## 2021 FH / SCC virtual internships

&lt;img src="img/people3.png" width="85%" style="display: block; margin: auto;" /&gt;

&lt;img src="img/internship_timeline3.PNG" width="70%" style="display: block; margin: auto;" /&gt;

---

## 2021 FH / SCC virtual internships

&lt;img src="img/people3.png" width="85%" style="display: block; margin: auto;" /&gt;

&lt;img src="img/internship_timeline4.PNG" width="70%" style="display: block; margin: auto;" /&gt;

---

## 2021 FH / SCC virtual internships

&lt;img src="img/people3.png" width="85%" style="display: block; margin: auto;" /&gt;

&lt;img src="img/internship_timeline5.PNG" width="70%" style="display: block; margin: auto;" /&gt;

---

## 2021 FH / SCC virtual internships

&lt;img src="img/people3.png" width="85%" style="display: block; margin: auto;" /&gt;

&lt;img src="img/internship_timeline6.PNG" width="70%" style="display: block; margin: auto;" /&gt;

---

## Internship projects at Fred Hutch

&lt;img src="img/people4.PNG" width="55%" style="display: block; margin: auto;" /&gt;

&amp;zwj;**Lucy:** developing .blue1[clinical trial protocols] for National Cancer Institute-funded clinical trials in .green[rare neuroendocrine tumors]. 

&amp;zwj;**Drew:** developing .blue1[guidelines] for using .blue2[machine learning] to do .blue2[variable screening] in risk-prediction analyses (e.g., cancer risk, COVID-19 risk, HIV-1 risk). 

---

## Closing thoughts

.blue1[Inference] on .blue2[model-agnostic] variable importance, using .green[machine learning]

.blue1[EDI work] can (and should) be .blue2[part of research]

A .green[strong community partner] (e.g., SCC) is crucial for this work

Many aspects needed for successful outreach: 
* positions (requires scientific staff as sponsors)
* administrative support (many thanks to **Jill Anderson**, **Tess Hurley**, and **Scientific Computing**)
* long-term commitment (many thanks to **Stephanie Shadbolt** and **Marilyn Saavedra-Leyva**)

.center[
<i class="fab  fa-github "></i> https://github.com/bdwilliamson | 
<i class="fas  fa-globe "></i> https://bdwilliamson.github.io
]
---

## References

* .small[ Benkeser, DC, Williamson BD, Magaret CA, Nizam S, and Gilbert PB. 2020. Super LeArner Prediction of NAb Panels (SLAPNAP): A Containerized Tool for Predicting Combination Monoclonal Broadly Neutralizing Antibody Sensitivity. _BioRxiv technical report_.]
* .small[ Breiman, L. 2001. Random forests. _Machine Learning_.]
* .small[ Koff, WC and Berkley, SF. 2010. The Renaissance in HIV vaccine development -- Future Directions. _The New England Journal of Medicine_  ]
* .small[ van der Laan, MJ. 2006. Statistical inference for variable importance. _The International Journal of Biostatistics_.]

---

## References

* .small[ Williamson B, Gilbert P, Carone M, and Simon N. 2020a. Nonparametric variable importance assessment using machine learning techniques (+ rejoinder to discussion). _Biometrics_. ]
* .small[ Williamson B, Gilbert P, Simon N, and Carone M. 2020b. A unified approach for inference on algorithm-agnostic variable importance. _ArXiv technical report_. ]
* .small[ Williamson B and Feng J. 2020. Efficient nonparametric statistical inference on population feature importance using Shapley values. _ICML_. ]
* .small[ Yoon H, Macke J, West AP, et al. 2015. CATNAP: a tool to compile, analyze and tally neutralizing antibody panels. _Nucleic Acids Research_. ]
    </textarea>
<style data-target="print-only">@media screen {.remark-slide-container{display:block;}.remark-slide-scaler{box-shadow:none;}}</style>
<script src="https://remarkjs.com/downloads/remark-latest.min.js"></script>
<script>var slideshow = remark.create({
"highlightStyle": "tomorrow-night-blue",
"highlightLanguage": "rmarkdown",
"highlightLines": false,
"slideNumberFormat": "%current%",
"countIncrementalSlides": false
});
if (window.HTMLWidgets) slideshow.on('afterShowSlide', function (slide) {
  window.dispatchEvent(new Event('resize'));
});
(function(d) {
  var s = d.createElement("style"), r = d.querySelector(".remark-slide-scaler");
  if (!r) return;
  s.type = "text/css"; s.innerHTML = "@page {size: " + r.style.width + " " + r.style.height +"; }";
  d.head.appendChild(s);
})(document);

(function(d) {
  var el = d.getElementsByClassName("remark-slides-area");
  if (!el) return;
  var slide, slides = slideshow.getSlides(), els = el[0].children;
  for (var i = 1; i < slides.length; i++) {
    slide = slides[i];
    if (slide.properties.continued === "true" || slide.properties.count === "false") {
      els[i - 1].className += ' has-continuation';
    }
  }
  var s = d.createElement("style");
  s.type = "text/css"; s.innerHTML = "@media print { .has-continuation { display: none; } }";
  d.head.appendChild(s);
})(document);
// delete the temporary CSS (for displaying all slides initially) when the user
// starts to view slides
(function() {
  var deleted = false;
  slideshow.on('beforeShowSlide', function(slide) {
    if (deleted) return;
    var sheets = document.styleSheets, node;
    for (var i = 0; i < sheets.length; i++) {
      node = sheets[i].ownerNode;
      if (node.dataset["target"] !== "print-only") continue;
      node.parentNode.removeChild(node);
    }
    deleted = true;
  });
})();
(function() {
  "use strict"
  // Replace <script> tags in slides area to make them executable
  var scripts = document.querySelectorAll(
    '.remark-slides-area .remark-slide-container script'
  );
  if (!scripts.length) return;
  for (var i = 0; i < scripts.length; i++) {
    var s = document.createElement('script');
    var code = document.createTextNode(scripts[i].textContent);
    s.appendChild(code);
    var scriptAttrs = scripts[i].attributes;
    for (var j = 0; j < scriptAttrs.length; j++) {
      s.setAttribute(scriptAttrs[j].name, scriptAttrs[j].value);
    }
    scripts[i].parentElement.replaceChild(s, scripts[i]);
  }
})();
(function() {
  var links = document.getElementsByTagName('a');
  for (var i = 0; i < links.length; i++) {
    if (/^(https?:)?\/\//.test(links[i].getAttribute('href'))) {
      links[i].target = '_blank';
    }
  }
})();</script>

<script>
slideshow._releaseMath = function(el) {
  var i, text, code, codes = el.getElementsByTagName('code');
  for (i = 0; i < codes.length;) {
    code = codes[i];
    if (code.parentNode.tagName !== 'PRE' && code.childElementCount === 0) {
      text = code.textContent;
      if (/^\\\((.|\s)+\\\)$/.test(text) || /^\\\[(.|\s)+\\\]$/.test(text) ||
          /^\$\$(.|\s)+\$\$$/.test(text) ||
          /^\\begin\{([^}]+)\}(.|\s)+\\end\{[^}]+\}$/.test(text)) {
        code.outerHTML = code.innerHTML;  // remove <code></code>
        continue;
      }
    }
    i++;
  }
};
slideshow._releaseMath(document);
</script>
<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
(function () {
  var script = document.createElement('script');
  script.type = 'text/javascript';
  script.src  = 'https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML';
  if (location.protocol !== 'file:' && /^https?:/.test(script.src))
    script.src  = script.src.replace(/^https?:/, '');
  document.getElementsByTagName('head')[0].appendChild(script);
})();
</script>
  </body>
</html>
